These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11844639)

  • 1. Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine.
    Fitzgibbon EJ; Hall P; Schroder C; Seely J; Viola R
    J Pain Symptom Manage; 2002 Feb; 23(2):165-70. PubMed ID: 11844639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.
    Fitzgibbon EJ; Viola R
    J Palliat Med; 2005 Feb; 8(1):49-57. PubMed ID: 15662173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration.
    Kronenberg RH
    J Pain Palliat Care Pharmacother; 2002; 16(3):27-35. PubMed ID: 14640353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with oral ketamine.
    Enarson MC; Hays H; Woodroffe MA
    J Pain Symptom Manage; 1999 May; 17(5):384-6. PubMed ID: 10355218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
    Kong PE; Snijdelaar DG; Crul BJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain.
    Mercadante S; Lodi F; Sapio M; Calligara M; Serretta R
    J Pain Symptom Manage; 1995 Oct; 10(7):564-8. PubMed ID: 8537699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine for pain: an update of uses in palliative care.
    Prommer EE
    J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
    Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ketamine in pain management.
    Visser E; Schug SA
    Biomed Pharmacother; 2006 Aug; 60(7):341-8. PubMed ID: 16854557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome.
    Soto E; Stewart DR; Mannes AJ; Ruppert SL; Baker K; Zlott D; Handel D; Berger AM
    Am J Hosp Palliat Care; 2012 Jun; 29(4):308-17. PubMed ID: 21803784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oral ketamine in chronic pain management: a review.
    Blonk MI; Koder BG; van den Bemt PM; Huygen FJ
    Eur J Pain; 2010 May; 14(5):466-72. PubMed ID: 19879174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analgesic effect of ketamine in a patient with neuropathic pain].
    Oye I; Rabben T; Fagerlund TH
    Tidsskr Nor Laegeforen; 1996 Oct; 116(26):3130-1. PubMed ID: 8999575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
    Rabben T; Øye I
    Eur J Pain; 2001; 5(3):233-40. PubMed ID: 11558979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.
    Backonja M; Arndt G; Gombar KA; Check B; Zimmermann M
    Pain; 1994 Jan; 56(1):51-57. PubMed ID: 8159441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.
    Mitchell AC
    J Pain Symptom Manage; 2001 May; 21(5):443-6. PubMed ID: 11369165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.
    Kiefer RT; Rohr P; Ploppa A; Dieterich HJ; Grothusen J; Koffler S; Altemeyer KH; Unertl K; Schwartzman RJ
    Pain Med; 2008 Nov; 9(8):1173-201. PubMed ID: 18266808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain.
    Webster LR; Walker MJ
    Am J Ther; 2006; 13(4):300-5. PubMed ID: 16858163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
    Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
    Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.